Carlsmed, a Carlsbad-based medical technology firm, began trading publicly on the Nasdaq Stock Market under the ticker symbol ...

DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology Approval represents critical advancement in early intervention for multiple myeloma ...

Conestoga lagged in Q2 as low-quality stocks surged, but stayed true to its focus on profitable small caps. See why they’re sticking with quality over hype ...

CMND-100, Clearmind’s lead compound, leverages the innovative molecule 5-methoxy-2-aminoindane (MEAI) to offer a potential breakthrough in AUD treatment. Preclinical studies have shown promising ...

While insider buying has been slow, there have been some notable, large purchases at a couple of biotech companies and ...

Sun Pharmaceutical Industries Ltd. closed 14.16% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

YieldMax Universe Fund of Option Income ETFs has stabilized after severe NAV erosion, now showing an uptrend. Read why YMAX ...

Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.

French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total ...

Sun Pharmaceutical Industries Ltd. closed 14.39% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...